Top View
- Drug Resistance of Human Immunodeficiency Virus and Overcoming It by Natural Products
- Antiretroviral Therapy for the Treatment of HIV
- Utah Medicaid Pharmacy and Therapeutics Committee Drug Class Review HIV-Combination Products
- Guide to Infection Control in the Healthcare Setting Hiv
- Pharmacology and Synthesis of Daurichromenic Acid As a Potent Anti-Hiv Agent
- Clinical Pharmacology in HIV Therapy
- Maraviroc – a CCR5 Antagonist for the Treatment of HIV-1 Infection
- Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate
- Management of Newborns Born to Women with HIV (Human Immunodeficiency Virus) Infection
- Product Monograph for RETROVIR/AZT
- Zidovudine Tablets Or Any of the Components (E.G., ZIDOVUDINE TABLETS Safely and Effectively
- Tea Polyphenols As Natural Products for Potential Future Management of HIV Infection
- RETROVIR (Zidovudine) Capsules, for Oral Use Toxicity, Myopathy, and Lactic Acidosis and Severe Hepatomegaly
- PACKAGE LEAFLET: INFORMATION for the USER DUOVIR N * (Lamivudine/Zidovudine /Nevirapine 150/ 300/200 Mg) Read All of This Leafl
- A Mouse Model Ofaids(MAIDS) for Testing
- Lamivudine/Nevirapine/Zidovudine 150 Mg/200 Mg/300 Mg Tablets
- Lamivudinezidovudinealphapha
- MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets
- Risk Management Plan Lamivudine / Zidovudine RMP Version 1.0
- TRIZIVIR Is a Fixed-Dose Tablet and Cannot Be Dose Adjusted, TRIZIVIR Safely and Effectively
- Efavirenz Versus Boosted Atazanavir Or Zidovudine and Abacavir in Antiretroviral Treatment–Naive, HIV-Infected Subjects: Week 48 Data from the Altair Study
- Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have Been Displaced by Disasters (Such As a Hurricane)
- Tenofovir Disoproxil Emtricitabine Efavirenz Mylan
- Descovy, INN-Emtricitabine / Tenofovir Alafenamide
- Page: Treatment-Drugs
- List Item Viread : EPAR
- MW Efficacy In
- Risks and Benefits of Dolutegravir-Based Antiretroviral Drug Regimens in Sub-Saharan Africa: a Modelling Study
- Mechanisms of Ccr5 Agonist/Antagonist Inhibition of Hiv-1
- Ccr5 Antagonists in Hiv Therapy
- (+)-Calanolide a of Wild-Type and Mutated Forms of HIV-1 Reverse Transcriptase
- Trizivir, INN-Abacavir-Lamivudine-Zidovudine
- Toxicology Reports 3 (2016) 336–345
- Page: Treatment-Drugs
- VIRACEPT (Nelfinavir Mesylate) TABLETS and ORAL POWDER
- MEDICATION GUIDE Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 300 Mg/300 Mg Co-Packaged with Nevirapine Tablets USP, 200 Mg
- Application for Listing of Zidovudine/Lamivudine/Abacavir for the Treatment of Hiv-1 Infection on the Who Model List of Essential Medicines
- Full Paper In
- Preventing Perinatal HIV Transmission
- Zidovudine (Retrovir)
- RETROVIR® (Zidovudine)
- Trizivir, INN-Abacavir, Lamivudine, Zidovudine
- Zidovudine 2020 Newborn Use Only
- Summary of Available Safety Data for Nevirapine, Stavudine, Zidovudine and Tenofovir
- Clinical Management Guidelines for Toxicities Related to Antiretrovirals
- Commentary: When to Start and What to Use in Children – Recommendations and Rationale
- Lamivudine, Nevirapine and Zidovudine
- Rescriptor® Prescribing Information
- Lamivudine, Nevirapine and Zidovudine Tablets 150Mg/200Mg/300Mg
- Anti-HIV Drugs for Cancer Therapeutics: Back to the Future?
- Title: the Nucleoside Analogues Zidovudine, Tenofovir Alafenamide
- Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens As Initial Therapy for HIV-1 Infection
- Zidovudine-Lamivudine (Combivir)
- Lamivudine/Nevirapine/Zidovudine – New Drug Approval
- PRESCRIBING INFORMATION Lamivudine 150 Mg/Zidovudine 300 Mg Tablets Co-Packaged with Efavirenz 600 Mg Tablets
- CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
- AIDS Drug Treatment